 PLYMOUTH MEETING, Pa. , Oct. 18, 2022 PRNewswire -- Harmony Biosciences Holdings, Inc. Harmony or the Company NASDAQ: HRMY, a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients with rare neurological diseases, today announced that it will report third quarter 2022 financial results on Tuesday, November 1, 2022, before the open of the U.S. financial markets. 